In This Section
FAQs for Clinical Research During the Coronavirus Pandemic
UPDATED MAY 20, 2020
Please see the May 20, 2020, update of the CHOP Research Institute FAQs for Clinical Research During the Coronavirus Pandemic for important frequently asked research questions related to the gradual, staged ramp-up of clinical trials and non-interventional clinical research.
As of May 26, clinical research staffing can ramp up to 25% staffing at any one time.
For example: Research group team members plus PI =12 people. Three individuals may be on the CHOP RI campus at any one time.
Please consult the FAQs for a Clinical Research Ramp-up timeline. Category I clinical research currently is permitted. Category II clinical research will be permitted beginning May 26.
Category I: Currently permitted
- Essential clinical trials, SARS-CoV-2 clinical research, fully remote clinical studies
Category II: Permitted May 26, 2020 for existing clinical studies
- In-person research visit CONCURRENT with clinical visit
- Research/biobank samples may be collected, provided the in-person research visit is concurrent with clinical visit AND the laboratory team can accept the research sample
The Clinical Research Support Office Leadership Team is available to discuss any questions about the gradual, staged return to clinical research with Principal Investigators. Contact ClinResearchQuestions [at] email.chop.edu for assistance.
COVID-19 Research Institute Updates
Check this COVID-19 Information and Resources page often for ongoing research communications and virtual opportunities. Visit the internal Bioresponse @CHOP Community for the latest bioresponse enterprise updates.